A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SLE / systemic lupus erythematosus

[Related PubMed/MEDLINE]
Total Number of Papers: 24680
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SLE  (>> Co-occurring Abbreviation)
Long Form:   systemic lupus erythematosus
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A case of systemic lupus erythematosus with rectal necrosis. ---
2020 A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus. anti-RibP, LN, NPSLE
2020 Abnormal topological organization in systemic lupus erythematosus: a resting-state functional magnetic resonance imaging analysis. FC
2020 Adherence to Antimalarial Therapy and Risk of Type 2 Diabetes Mellitus among Patients with Systemic Lupus Erythematosus: A Population-Based Study. CI, PDC, T2DM
2020 Analysis of IL-22 and Th22 Cells by Flow Cytometry in Systemic Lupus Erythematosus. IL, Th
2020 Antibodies against carbamylated vimentin exist in systemic lupus erythematosus and correlate with disease activity. anti-CarP, ESR, IgG, pSS, RA, RBC
2020 Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective. ACR, EULAR, SLICC
2020 Association between FAS gene -670 A/G and -1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis. CIs, HT, MS, ORs, SSc
2020 Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE. aSLE, cSLE, GRSs, OR
10  2020 Atherosclerotic Vascular Events in Systemic Lupus Erythematosus: An Evolving Story. AVE, PY
11  2020 Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid. AVN
12  2020 Causal association between periodontitis and risk of rheumatoid arthritis and systemic lupus erythematosus: aMendelian randomization. GWAS, IVW, MR, RA
13  2020 Cerebral venous sinus thrombosis as the initial presentation of systemic lupus erythematosus. CVST
14  2020 Choroidal thickness in lupus nephritis. LN
15  2020 Clinical significance of reduced expression of lncRNA TUG1 in the peripheral blood of systemic lupus erythematosus patients. lncRNA TUG1, ROC
16  2020 Combined Assay for Detecting Autoantibodies to Nucleic Acids and Apolipoprotein H in Patients with Systemic Lupus Erythematosus. ADs
17  2020 Comparison of an administrative algorithm for SLE disease severity to clinical SLE Disease Activity Index scores. BWH
18  2020 Comparison of chemiluminescence microparticle immunoassay, indirect immunofluorescence assay, linear immunoassay and multiple microbead immunoassay detecting autoantibodies in systemic lupus erythematosus. ANA, CMIA, HCs, IIFA, LIA, MBI
19  2020 Comparison of lupus patients with early and late onset nephritis: a study in 71 patients from a single referral center. ---
20  2020 Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study. GEE, GRC, HRQoL, LLDAS
21  2020 Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus. ACR, CB-CAPs, MAP, SLICC, SS
22  2020 Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus. FI, SLICC
23  2020 Correlation between albumin to fibrinogen ratio, C-reactive protein to albumin ratio and Th17 cells in patients with rheumatoid arthritis. AFR, CAR, ESR, HD, RF
24  2020 Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjogrens syndrome. HC, pSS, SADs, SSc
25  2020 Damage accrual related to pregnancies before and after diagnosis of systemic lupus erythematosus: a cross-sectional and nested case-control analysis from a lupus registry. SDI
26  2020 Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus. AUC, RA, ROC, Sema3A, Sema7A, SS
27  2020 Dietary patterns and risk of systemic lupus erythematosus in women. CI, HR
28  2020 Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry). EC, LAM
29  2020 Different patterns of cerebral perfusion in SLE patients with and without neuropsychiatric manifestations. ASL, CBF, NCs, ROC, SLEDAI, SLICC, SVM, VBA, WM
30  2020 Differential Responsiveness of Monocyte and Macrophage Subsets to Interferon. IFN, PBMCs, qPCR
31  2020 DNA Vaccination with Heat Shock Protein 70 Protects (NZB x NZW)F1 Mice from Systemic Lupus Erythematosus. ELISA, HSP
32  2020 Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9. ESR, HDAC9, IFN, IL, miR-101-3p, PBMCs
33  2020 Dysregulated Fcgamma receptor IIa-induced cytokine production in dendritic cells of lupus nephritis patients. DCs, FcgammaRIIa, IFNs, Ig, IL, IRF
34  2020 Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus. CI, OR, PCR-RFLP, PDCD1, SNPs
35  2020 Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. SRI-4
36  2020 Elevated Blood and Urinary ICAM-1 is a Biomarker for Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. CI, ICAM-1, SMD, SMD
37  2020 Emerging views of mitophagy in immunity and autoimmune diseases. IBD, PBC
38  2020 Endomyocardial biopsies in the diagnosis of myocardial involvement in systemic lupus erythematosus. EMB
39  2020 Epidemiology and outcomes of sepsis among hospitalizations with systemic lupus erythematosus admitted to the ICU: a population-based cohort study. ---
40  2020 Epilepsy in systemic lupus erythematosus: prevalence and risk factors. APS, NPSLE
41  2020 Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient-Reported Outcomes Measurement Information System Short Forms in Systemic Lupus Erythematosus. MIDs, PASS, PROMIS
42  2020 Familial lupus in Tunisia: a series of 14 families. ---
43  2020 Fragmented QRS complex in patients with systemic lupus erythematosus at the time of diagnosis and its relationship with disease activity. fQRS, IQR
44  2020 Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus. IFN, MDSCs
45  2020 High Burden of Premature Arteriosclerosis on Renal Biopsies in Incident Lupus Nephritis. CVD, LN
46  2020 High Prevalence and Disease Correlation of Autoantibodies Against p40 Encoded by Long Interspersed Nuclear Elements in Systemic Lupus Erythematosus. ELISA, LINE-1, ORF2p
47  2020 High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy. CVD, HDLs
48  2020 Identifying the differentially expressed microRNAs in autoimmunity: A systemic review and meta-analysis. miRNAs, RA, T1D
49  2020 Impact of markers of endothelial injury and hypercoagulability on systemic lupus erythematosus. DDi, TG, TM
50  2020 Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis. BLC, CI, CNKI, CXCL13, RA, SLEDAI, SMD
51  2020 Indeterminate cell histiocytosis in a patient with systemic lupus erythematosus and antiphospholipid antibody syndrome: an unusual association. ICH
52  2020 Interleukin-17 and lupus: enough to be a target? For which patients? IL
53  2020 Lessons from precision medicine in rheumatology. RA
54  2020 Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/RAB4 expression and mTOR activation. LTR, mTOR
55  2020 Managing pregnancy-associated clinical emergencies in systemic lupus erythematosus: a case-based approach. abeta2GP1, aPL, LN, TTP
56  2020 Methionine commits cells to differentiate into plasmablasts through epigenetic regulation of BTB and CNC homolog 2 by the methyltransferase enhancer of zeste homolog 2. Bach2, EZH2, mTORC1
57  2020 Mobile health technologies for the management of systemic lupus erythematosus: a systematic review. apps, MARS, mHealth
58  2020 Molecular mechanism of celastrol in the treatment of systemic lupus erythematosus based on network pharmacology and molecular docking technology. ---
59  2020 Monoclonal anti-dsDNA antibody 2C10 escorts DNA to intracellular DNA sensors in normal mononuclear cells and stimulates secretion of multiple cytokines implicated in lupus pathogenesis. AIM2, IFN, IL, MCP-1, PBMCs, TLR, TNF
60  2020 Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic. AICTD, APS, IIM, MCTD, NFC, RP, SSc
61  2020 Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach. HRQoL, NP, SF
62  2020 Neutrophil proteases degrade autoepitopes of NET-associated proteins. NE, NETs, RA
63  2020 Objectively Assessed Foot and Ankle Characteristics in Patients With Systemic Lupus Erythematosus: A Comparison With Age- and Sex-Matched Controls. ABI, OR, VPT
64  2020 Peripheral Gangrene as the Initial Presentation of Systemic Lupus Erythematosus in Emergency Department. ---
65  2020 Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. NP, PNS, SF-36
66  2020 Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A PhaseI, Open-Label Study. BLyS, PD, PK
67  2020 Preterm birth phenotypes in women with autoimmune rheumatic diseases: a population-based cohort study. JIA, PPROM, PTB, RA, RRs, SSc
68  2020 Prevalence and incidence of systemic lupus erythematosus and associated outcomes in the 2009-2016 US Medicare population. ---
69  2020 Progranulin Mediates Proinflammatory Responses in Systemic Lupus Erythematosus: Implications for the Pathogenesis of Systemic Lupus Erythematosus. PGRN, WT
70  2020 Rare case of bilateral wrist and foot drop from SLE-related vasculitic polyneuropathy. ---
71  2020 Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States. ---
72  2020 Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate. anti-P
73  2020 Role of Inflammasome Activation in Systemic Lupus Erythematosus: Are Innate Immune Cells Activated? PBMCs
74  2020 Safety and tolerability of anifrolumab, a monoclonal antibody targeting type I interferon receptor, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study. AE, IFN, SAE
75  2020 Safety and tolerability of sifalimumab, an anti-interferon-alpha monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study. AEs
76  2020 Sensitivity and specificity of Interleukin 29 in patients with rheumatoid arthritis and other rheumatic diseases. FM, LR, OA, RA, SSc
77  2020 Septicaemia is associated with increased disease activity and mortality in systemic lupus erythematosus: a retrospective analysis from Taiwan. ---
78  2020 Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease. CVD
79  2020 Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus. SDI, SLICC, suPAR
80  2020 Speckle tracking echocardiography in patients with systemic lupus erythematosus: A meta-analysis. GLS, STE
81  2020 Structural and functional brain connectomes in patients with systemic lupus erythematosus. ADNA, MRI, NP
82  2020 Successful treatment with hydroxychloroquine for systemic lupus erythematosus with cutaneous involvement accompanied by a xanthomatous reaction. DLE, HCQ, PSL
83  2020 Suppression of systemic lupus erythematosus in NZBWF1 mice infected with Hymenolepis microstoma. Hm
84  2020 Systemic lupus erythematosus in Native sub-Saharan Africans: A systematic review and meta-analysis. ---
85  2020 Systemic lupus erythematosus in the setting of HIV-1 infection: a longitudinal analysis. LUMINA
86  2020 T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy. ---
87  2020 The Antiphospholipid Syndrome -often overlooked cause of vascular occlusions? aPL, APS
88  2020 The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8T Cell Function and Identifies Patients with SLE Prone to Infections. ---
89  2020 The IL-12-STAT4 axis in the pathogenesis of human systemic lupus erythematosus. ---
90  2020 The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial. DASH, HAQ, LupusQoL, VAS
91  2020 The impacts of resilience on the association between illness uncertainty and sleep quality among Chinese women with systemic lupus erythematosus. CD-RISR, MUIS-A, PSQI
92  2020 The polymorphism rs13259960 in SLEAR predisposes to systemic lupus erythematosus. lncRNAs
93  2020 The protection of NF-kappaB inhibition on kidney injury of systemic lupus erythematosus mice may be correlated with lncRNA TUG1. ANA, anti-dsDNA, NF-kappaB
94  2020 The role of nuclear factors as "Find-Me"/alarmin signals and immunostimulation in defective efferocytosis and related disorders. AC, MSU, NCs
95  2020 The Serum Cell-Free microRNA Expression Profile in MCTD, SLE, SSc, and RA Patients. ACTDs, MCTD, RA, SSc, TLRs
96  2020 Time to progression from discoid lupus erythematosus to systemic lupus erythematosus: a retrospective cohort study. DLE
97  2020 Toll-like receptor signalling associated with immunomodulation of umbilical cord-derived mesenchymal stem cells in mice with systemic lupus erythematosus. MSCs, MyD88
98  2020 Trial of Anifrolumab in Active Systemic Lupus Erythematosus. BILAG
99  2020 Tubercular meningitis in patients with systemic lupus erythematosus: clinical characteristics, risk factors, and outcomes of 10 patients. CNS, TBM
100  2020 Type II but Not Type I IFN Signaling Is Indispensable for TLR7-Promoted Development of Autoreactive B Cells and Systemic Autoimmunity. AFC, GC, Tfh